What is Alto Pharmacy?
Alto Pharmacy operates at the intersection of healthcare and technology, aiming to revolutionize how patients interact with their medications. By integrating expert pharmacist care with an advanced digital platform, the company simplifies prescription fulfillment, enhances medication adherence, and improves communication channels between patients, care teams, and industry partners. This integrated digital approach positions Alto Pharmacy as a key player in the evolving landscape of healthcare delivery, focusing on patient-centric solutions and operational efficiency.
How much funding has Alto Pharmacy raised?
Alto Pharmacy has raised a total of $564.8M across 6 funding rounds:
Series B
$23M
Series C
$50M
Series D
$250M
Series E
$200M
Debt
$1.8M
Debt
$40M
Series B (2017): $23M with participation from Jackson Square Ventures and GREENOAKS
Series C (2018): $50M led by SoftBank Vision Fund 2
Series D (2020): $250M supported by Jackson Square Ventures, SoftBank Group Corp, Greenoaks, OliveTree Capital, and Zola Global Investors
Series E (2022): $200M featuring Softbank Vison Fund
Debt (2024): $1.8M backed by US Bank Tower
Debt (2024): $40M with participation from SoftBank Group
Key Investors in Alto Pharmacy
SoftBank Group
SoftBank Group is a global technology holding company that invests in and supports innovative businesses across various sectors, including telecommunications, AI, and smart robotics, with a focus on shaping the future of technology.
Jackson Square Ventures
Jackson Square Ventures is a Series A investment firm that focuses on software and marketplace businesses, partnering with founders to build iconic companies and drive industry transformation.
Zola Global Investors
Zola Global Investors is an operationally focused family office that deploys capital to help management teams build sustainable businesses across various industries globally, with a focus on intellectual property and supply chain positions.
What's next for Alto Pharmacy?
With the recent influx of major strategic investment and substantial enterprise-level backing, Alto Pharmacy is poised for significant expansion. The company is likely to leverage this capital to further enhance its technology platform, broaden its service offerings, and potentially scale its operations into new markets. This strategic financing suggests a focus on solidifying its market leadership and continuing its trajectory of innovation in the digital pharmacy space, aiming to further improve patient outcomes and streamline healthcare logistics.
See full Alto Pharmacy company page
